Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 1;64(4):876-885.
doi: 10.1097/GRF.0000000000000655.

Prenatal Gene Therapy

Marisa E Schwab  1   2 , Tippi C MacKenzie  1   2
Affiliations

Prenatal Gene Therapy

Marisa E Schwab et al. Clin Obstet Gynecol. .

Abstract

Prenatal gene therapy could provide a cure for many monogenic diseases. Prenatal gene therapy has multiple potential advantages over postnatal therapy, including treating before the onset of disease, the ability to induce tolerance and cross the blood-brain barrier. In this chapter, we will describe in utero gene therapy and its rationale, clinical trials of postnatal gene therapy, preclinical studies of in utero gene therapy, and potential risks to the mother and fetus.

PubMed Disclaimer

References

    1. Liley AW. Intrauterine transfusion of foetus in haemolytic disease. Br Med J. 1963;2:1107–1109.
    1. Yuan SM. Fetal arrhythmias: diagnosis and treatment. J Matern Fetal Neonatal Med. 2020;33:2671–2678.
    1. Davidson KM, Richards DS, Schatz DA, et al. Successful in utero treatment of fetal goiter and hypothyroidism. N Engl J Med. 1991;324:543–546.
    1. US National Institutes of Health. Recombinant DNA Advisory Committee. Prenatal gene tranfer: scientific, medical, and ethical issues: a report of the Recombinant DNA Advisory Committee. Hum Gene Ther. 2000;11:1211–1229.
    1. Almeida-Porada G, Atala A, Porada CD. In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application. Mol Ther Methods Clin Dev. 2016;5:16020.